首頁 > 市場調查報告書 > 食物/飲料

食品添加劑機能性食品

市場調查報告書

商品編碼

1674217

人乳寡糖市場：按應用、類型和地區分類

Human Milk Oligosaccharides Market, By Application, By Type, By Geography

出版日期: 2025年02月20日 | 出版商:

Coherent Market Insights | 英文 120 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2025 年全球人乳寡糖市場規模估計為 3.425 億美元，預計到 2032 年將達到 8.952 億美元，2025 年至 2032 年的複合年成長率為 14.7%。

報告範圍		報告詳細資訊
基準年	2024	2025 年市場規模	3.425億美元
效能資料	2020-2024	預測期	2025-2032
預測期：2025 年至 2032 年複合年成長率	14.70％	2032 年金額預測	8.952億美元

數字。 2025 年人乳寡糖市場佔有率（按地區分類）

人乳寡糖(HMO) 是母乳中發現的複合糖，已被證明可以支持有益腸道細菌的生長並保護嬰兒免受致病細菌的侵害。作為母乳中繼乳糖和脂肪之後第三豐富的固態成分，HMO 模仿嬰兒腸道黏膜內壁的成分，防止病原體附著和定植在腸壁上。研究和開發表明，HMO 可以促進嬰兒的大腦發育並刺激免疫細胞發育。由於 HMO 具有與人類母乳相似的益生元和營養特性，因此被添加至嬰兒奶粉中，為奶瓶餵食的嬰兒提供健康益處。

市場動態

全球人乳寡糖對 HMO 在嬰兒營養和市場發展中的重要性的認知不斷提高的推動。由於許多母親在哺乳方面面臨挑戰，對 HMO 強化嬰兒奶粉的需求大幅增加。主要市場參與企業已經開發出透過發酵各種乳製品和植物材料生產 HMO 的技術能力。然而，生產過程的高成本對市場成長構成了挑戰。正在進行的致力於降低生產成本的研究可能會為 HMO 在嬰兒營養以外的領域（臨床營養、個人護理以及補充食品和飲料等領域）的更廣泛應用開闢機會。

研究的主要特點

本報告對全球人乳寡糖市場進行了詳細分析，並提供了預測期（2025-2032）的市場規模和年複合成長率（CAGR%），以 2024 年為基準年。
它還揭示了各個領域的潛在商機，並解釋了該市場有吸引力的投資提案矩陣。
它還提供了對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。
它根據公司亮點、產品系列、關鍵亮點、績效和策略等參數，介紹了全球人乳寡糖市場的主要企業概況。
本報告的見解將使負責人和企業經營團隊能夠就未來產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
全球人乳寡糖市場報告迎合了該行業的各個相關人員，例如投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
相關人員可以透過全球人乳寡糖市場分析中使用的各種策略矩陣更輕鬆地做出決策。

市場佔有率分析
公司簡介
- ZuChem Inc.
- Merck & Co. Inc.
- Chr. Hansen Holding AS
- Royal FrieslandCampina NV
- BASF
- IFF（DuPont Nutrition & Health）
- GnubIoTics
- Inbiose NV
- Carbosynth Holdings Limited
- Royal DSM NV
- Kyowa Hakko Europe GmbH
- Elicityl SA
- FrieslandCampina Ingredients
- Glycom A/S
- Dextra Laboratories Limited
- Rajvi Enterprise

第 9 章分析師建議

興衰
一致的機會地圖

第 10 章章節

參考
調查方法

簡介目錄

Product Code: CMI5064

Global Human Milk Oligosaccharides Market is estimated to be valued at USD 342.5 Mn in 2025 and is expected to reach USD 895.2 Mn by 2032, growing at a compound annual growth rate (CAGR) of 14.7% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 342.5 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	14.70%	2032 Value Projection:	USD 895.2 Mn

Figure. Human Milk Oligosaccharides Market Share (%), By Region 2025

Human Milk Oligosaccharides Market - IMG1

Human milk oligosaccharides (HMOs) are complex sugars found in breastmilk that support the growth of beneficial gut bacteria in infants and provide protection against pathogenic bacteria. As the third most abundant solid component in breastmilk after lactose and fat, HMOs mimic components of the mucosal layer in the infant gut and prevent pathogens from attaching to and colonizing the intestinal wall. Research has shown that HMOs can promote brain development and stimulate immune cell development in infants. Due to their demonstrated prebiotic and nutritional properties similar to human breastmilk, HMOs are being incorporated into infant formula to deliver health benefits to bottle-fed babies.

Market Dynamics:

The global human milk oligosaccharides market is driven by growing awareness about the importance of HMOs in infant nutrition and development. As many mothers face difficulties in breastfeeding, the demand for HMO-fortified infant formula is increasing significantly. Major market players have developed technological capabilities to produce HMOs through the fermentation of various dairy and plant-based ingredients. However, the high costs involved in the production process pose a challenge to market growth. Ongoing research focused on reducing production costs could open up opportunities for the wider application of HMOs beyond infant nutrition in areas such as clinical nutrition, personal care, and supplemental food & beverages.

Key Features of the Study:

This report provides in-depth analysis of the global human milk oligosaccharides market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global human milk oligosaccharides market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include ZuChem Inc., Merck & Co. Inc., Chr. Hansen Holding AS , Royal FrieslandCampina NV, BASF, IFF (DuPont Nutrition & Health), Gnubiotics, Inbiose NV, Carbosynth Holdings Limited, Royal DSM N.V, Kyowa Hakko Europe GmbH, Elicityl SA, FrieslandCampina Ingredients, Glycom A/S, Dextra Laboratories Limited, and Rajvi Enterprise
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global human milk oligosaccharides market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global human milk oligosaccharides market

Detailed Segmentation-

By Application:
- Infant Formula
- Dietary Supplements
- Functional Food and Beverage
By Type:
- 2'FL
- 3'FL
- 3'SL
- 6'SL
- LNT
- LNnT
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Company Profiles:
- ZuChem Inc.
- Merck & Co. Inc.
- Chr. Hansen Holding AS
- Royal FrieslandCampina NV
- BASF
- IFF (DuPont Nutrition & Health)
- Gnubiotics
- Inbiose NV
- Carbosynth Holdings Limited
- Royal DSM N.V
- Kyowa Hakko Europe GmbH
- Elicityl SA
- FrieslandCampina Ingredients
- Glycom A/S
- Dextra Laboratories Limited
- Rajvi Enterprise

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Application
- Market Snippet, By Type
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- PEST Analysis
- PORTER's Five Forces Analysis
- Market Opportunities
- Regulatory Scenario
- Industry Trend
- Mergers and Acquisitions

4. Global Human Milk Oligosaccharides Market - Impact of Coronavirus (COVID-19) Pandemic

Overview
Factors Affecting the Global Human Milk Oligosaccharides Market
Impact Analysis

5. Global Human Milk Oligosaccharides Market, By Application, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025, 2028 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Infant Formula
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
- Segment Trends
Dietary Supplements
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
- Segment Trends
Functional Food and Beverage
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
- Segment Trends

6. Global Human Milk Oligosaccharides Market, By Type, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025, 2028 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
2'FL
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
- Segment Trends
3'FL
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
- Segment Trends
3'SL
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
- Segment Trends
6'SL
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
- Segment Trends
LNT
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
- Segment Trends
LNnT
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
- Segment Trends

7. Global Human Milk Oligosaccharides Market, By Region, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, By Region, 2025, 2028 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021-2032
North America
- Introduction
- Market Size and Forecast, By Application, 2020 - 2032, (US$ Mn)
- Market Size and Forecast, By Type, 2020 - 2032, (US$ Mn)
- Market Size and Forecast, By Country, 2020 - 2032, (US$ Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Application, 2020 - 2032, (US$ Mn))
- Market Size and Forecast, By Type, 2020 - 2032, (US$ Mn)
- Market Size and Forecast, By Country, 2020 - 2032, (US$ Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Application, 2020 - 2032, (US$ Mn)
- Market Size and Forecast, By Type, 2020 - 2032, (US$ Mn)
- Market Size and Forecast, By Country, 2020 - 2032, (US$ Mn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Application, 2020 - 2032, (US$ Mn)
- Market Size and Forecast, By Type, 2020 - 2032, (US$ Mn)
- Market Size and Forecast, By Country, 2020 - 2032, (US$ Mn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East & Africa
- Introduction
- Market Size and Forecast, By Application, 2020 - 2032, (US$ Mn)
- Market Size and Forecast, By Type, 2020 - 2032, (US$ Mn)
- Market Size and Forecast, By Country, 2020 - 2032, (US$ Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East & Africa

8. Competitive Landscape

Market Share Analysis
Company Profiles
- ZuChem Inc.
  - Company Overview
  - Application Portfolio
  - Recent Developments/Updates
- Merck & Co. Inc.
  - Company Overview
  - Application Portfolio
  - Recent Developments/Updates
- Chr. Hansen Holding AS
  - Company Overview
  - Application Portfolio
  - Recent Developments/Updates
- Royal FrieslandCampina NV
  - Company Overview
  - Application Portfolio
  - Recent Developments/Updates
- BASF
  - Company Overview
  - Application Portfolio
  - Recent Developments/Updates
- IFF (DuPont Nutrition & Health)
  - Company Overview
  - Application Portfolio
  - Recent Developments/Updates
- Gnubiotics
  - Company Overview
  - Application Portfolio
  - Recent Developments/Updates
- Inbiose NV
  - Company Overview
  - Application Portfolio
  - Recent Developments/Updates
- Carbosynth Holdings Limited
  - Company Overview
  - Application Portfolio
  - Recent Developments/Updates
- Royal DSM N.V
  - Company Overview
  - Application Portfolio
  - Recent Developments/Updates
- Kyowa Hakko Europe GmbH
  - Company Overview
  - Application Portfolio
  - Recent Developments/Updates
- Elicityl SA
  - Company Overview
  - Application Portfolio
  - Recent Developments/Updates
- FrieslandCampina Ingredients
  - Company Overview
  - Application Portfolio
  - Recent Developments/Updates
- Glycom A/S
  - Company Overview
  - Application Portfolio
  - Recent Developments/Updates
- Dextra Laboratories Limited
  - Company Overview
  - Application Portfolio
  - Recent Developments/Updates
- Rajvi Enterprise
  - Company Overview
  - Application Portfolio
  - Recent Developments/Updates